Pharmacodynamics of fluconazole in a murine model of systemic candidiasis

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 5, 1998, Pages 1105-1109

  Louie, Arnold ^a,b   Drusano, George L ^a   Banerjee, Partha ^a,b   Liu, Qing Feng ^a,b   Liu, Weiguo ^a   Kaw, Pamela ^a   Shayegani, Mehdi ^b   Taber, Harry ^b   Miller, Michael H ^a,b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CANDIDIASIS; COMPARTMENT MODEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; FUNGICIDAL ACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031966359     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.5.1105     Document Type: Article

References (25)

1. Akaike, H. 1974. A new look at the statistical model identification. IEEE Trans. Automated Control 19:716-723.
2. Anaissie, E. J., R. O. Darouiche, D. Abi-Said, O. Uzun, J. Mera, L. O. Gentry, T. Williams, D. P. Kontoyiannis, C. L. Karl, and G. P. Bodey. 1996. Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature. Clin. Infect. Dis. 23:964-972.
3. Beck-Sague, C. M., W. R. Jarvis, and the National Nosocomial Infections Surveillance System. 1993. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J. Infect. Dis. 167:1247-1251.
4. Billelo, J. A., G. Bauer, M. N. Dudley, G. A. Cole, and G. L. Drusano. 1994. Effect of 2′,3′-didehydro-3′-desoxythymidine in an in vitro hollow-fiber pharniacodynamic model system correlates with results of dose-ranging clinical studies. Antimicrob. Agents Chemother. 38:1386-1391.
5. Bilello, J. A., J. L. Eiseman, H. C. Standiford, and G. L. Drusano. 1994. Impact of dosing schedule upon suppression of a retrovirus in a murine model of AIDS. Antimicrob. Agents Chemother. 38:628-631.
6. Bodey, G. P., S. J. Ketchel, and V. Rodriguez. 1979. A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients. Am. J. Med. 67:608-616.
7. Drusano, G. L. 1988. Role of pharmacokinetics in the outcome of infections. Antimicrob. Agents Chemother. 32:289-297.
8. Drusano, G. L., D. E. Johnson, M. Rosen, and H. C. Standiford. 1993. Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas aeruginosa sepsis. Antimicrob. Agents Chemother. 37:483-490.
9. Fluckiger, U., C. Segessenmann, and A. U. Gerber. 1991. Integration of pharmacokinetics and pharmacodynamics of imipenem in a human-adapted mouse model. Antimicrob. Agents Chemother. 35:1905-1910.
10. Forrest, A., D. E. Nix, C. H. Ballow, T. F. Goss, M. C. Birmingham, and J. J. Schentag. 1993. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob. Agents Chemother. 37:1073-1081.
11. Gerber, A. U., P. Wiprachtiger, U. Stettler-Spichiger, and G. Lebek. 1982. Constant infusion vs. intermittent doses of gentamicin against Pseudomonas aeruginosa in vitro. J. Infect. Dis. 145:554-560.
12. Grant, S. M., and S. P. Clissold. 1990. Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 39:877-916.
13. Jorgensen, J. H., G. A. Alexander, J. R. Graybill, and D. J. Drutz. 1981. Sensitive bioassay for ketoconazole in serum and cerebrospinal fluid. Antimicrob. Agents Chemother. 20:59-62.
14. Leggett, J. E., S. Ebert, B. Fantin, and W. A. Craig. 1991. Comparative dose-effect relations at several dosing intervals for beta-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection and pneumonitis models. Scand. J. Infect. Dis. 74:179-184.
15. Louie, A., C. Chan, M. Mayers, R. Perkins, G. Drusano, E. Anaissie, and M. Miller. 1995. Dosing of fluconazole in rabbits to achieve pharmacokinetic parameters that mimic those of high-dose fluconazole in humans, abstr. A-119, p. 164. In Abstracts of the 95th General Meeting of the American Society for Microbiology 1995. American Society for Microbiology, Washington, D.C.
16. Madu, A., C. Cioffe, U. Mian, M. Burroughs, E. Toumanen, M. Mayers, E. Schwartz, and M. Miller. 1994. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum of rabbits: validation of an animal model used to measure drug concentration in cerebrospinal fluid. Antimicrob. Agents Chemother. 38:2111-2115.
17. Moore, R. D., P. S. Lietman, and C. R. Smith. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J. Infect. Dis. 155:93-99.
18. National Committee for Clinical Laboratory Standards. 1995. Reference method for broth dilution antifungal susceptibility testing for yeast; tentative standard. M27-T. National Committee for Clinical Laboratory Standards, Wayne, Pa.
19. Powell, S. H., W. L. Thompson, M. A. Luthe, R. C. Stern, D. A. Grossniklaus, D. D. Bloxham, D. L. Groden, M. R. Jacobs, A. O. DiScenna, H. A. Cash, and J. D. Klinger. 1983. Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin. J. Infect. Dis. 147:918-932.
20. Rex, J. H., J. E. Bennett, A. M. Sugar, P. G. Pappas, C. M. Van der Horst, J. E. Edwards. R. G. Washburn, W. M. Scheld, A. W. Karchmer, A. P. Dine, M. J. Levenstein, C. D. Webb, the Candidemia Study Group, and the NIAID Mycoses Study Group. 1994. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N. Engl. J. Med. 331:1325-1330.
21. Roosendaal, R., I. A. Bakker-Woudenberg, M. van den Berghe-van Raffe, and M. F. Michel. 1986. Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats. Antimicrob. Agents Chemother. 30:403-408.
22. Schentag, J. J., I. L. Smith, D. J. Swanson, C. DeAngelis, J. E. Fracasso, A. Vari, and J. W. Vance. 1984. Role for dual individualization with cefmenoxime. Am. J. Med. 77(Suppl. 6a):43-50.
23. Solomkin, J. S., A. M. Flohr, and R. L. Simmons. 1982. Indications for therapy for fungemia in postoperative patients. Arch. Surg. 117:1272-1275.
24. Vogelman, B., S. Gudmundsson, J. Leggett, J. Turnidge, S. Ebert, and W. A. Craig. 1988. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J. Infect. Dis. 158:831-847.
25. Wey, S. B., M. Mori, M. A. Pfaller, R. F. Woolson, and R. P. Wenzel. 1988. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch. Intern. Med. 148:2642-2645.